First-in-human Phase 1 study is expected to initiate in the first half of 2026, pending regulatory clearance Preparations for dose-ranging Phase 2 study of NPM-139 to occur in parallel with Phase 1 ...
Software supply chain security firm JFrog has disclosed the details of a critical vulnerability affecting a popular React ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback